BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a significant milestone in its advanced tissue regeneration strategy: the first Phasix™ Mesh ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition ...
36mon MSN
This Brazilian Berry May Reduce Inflammation, Support Gut Health, and Help Balance Blood Sugar
Açai isn’t the only Brazilian fruit with superfood potential, according to emerging research. Jaboticaba is rich in ...
The study found that electricity-free housing modifications lowered indoor temperatures by up to 3.3°C and reduced malaria-carrying mosquito populations by as much as 77 percent in western Kenya. - ...
There are critical gaps in biosimilar adoption for pediatric patients, focusing on safety, regulatory challenges, and the ...
GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback